Frontlight ResearchEarly access
Trial site
Covenant Health Oncology Group - Lenoir City
- 5running trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers2 trials
- Colorectal cancer1 trial
- Head and neck cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 33 trials
- Phase 2/31 trial
- Status
- Active, not recruiting5 trials
- Lead sponsor
- National Cancer Institute (NCI)5 trials
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Site data: ClinicalTrials.govUpdated 19 Nov 2026